 |
| Article |
| Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice |
 |
| Hiroaki Honda1, Koichiro Harada1,a, Issei Komuro1, Fumio Terasaki2, Hiroo Ueno1, Yuji Tanaka1, Keishiro Kawamura2, Yoshio Yazaki1 and Hisamaru Hirai1,a |
 |
1Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113, Japan
2Third Department of Internal Medicine, Faculty of Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki-shi, Osaka, 569, Japan
|
 |
Correspondence to: Hisamaru Hirai, Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113, Japan
|  |
aH Hirai and K Harada equally contributed to this work |
 |
| Abstract |
 | Leukocyte tyrosine kinase (LTK) is a receptor-type protein tyrosine kinase belonging to the insulin receptor superfamily. To elucidate its biological role, we generated transgenic mice expressing LTK under the control of cytomegarovirus enhancer and -actin promoter. The transgenic mice exhibited growth retardation and most of the transgenic mice died within several months after birth. Interestingly, although LTK was expressed in several major organs, the activation (tyrosine-phosphorylation, kinase activity, and multimerization) of LTK was observed selectively in the heart, where LTK was localized on intracellular membrane, presumably on endoplasmic reticulum. Echocardiography showed that the transgenic heart underwent severe concentric hypertrophy, which resulted in reduced cardiac output, low blood pressure, and increased heart rate. Histological examination of the heart exhibited focal degeneration of cardiomyocytes. These histological changes were considered to be due to apoptosis, based on the finding that the sarcolemmas of the degenerative cardiomyocytes were well preserved. In addition, expression of fetal genes, such as atrial natriuretic peptide and skeletal -actin, was markedly induced in the transgenic heart. These results indicate that a certain tissue-specific mechanism of activating LTK exists in the heart and that the activated LTK resulted in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming. These findings will provide novel insights into the activating mechanism and biological role of LTK in vivo. |
 |
| Keywords |
 | leukocyte tyrosine kinase (LTK); protein tyrosine kinase; transgenic mice |
|
 |
 |
 |
| Received 20 July 1998; revised 25 January 1999; accepted 25 January 1999 |
 |
| 1 July 1999, Volume 18, Number 26, Pages 3821-3830 |
| Table of contents Previous Abstract Next Full text PDF |
|